This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Younger, J. W. Articles by Keenum, A. J. Search for Related Content PubMed PubMed Citation Articles by Younger, J. W. Articles by Keenum, A. J. Related Collections Psychophysiology Stress and Coping Blood Pressure

Effects of Naltrexone on Repressive Coping and Disclosure of Emotional Material: A Test of the Opioid-Peptide Hypothesis of Repression and Hypertension

From the Division of Pain Management, Department of Anesthesia, Stanford University School of Medicine, Palo Alto, California (J.W.Y.); the Department of Psychology, University of Tennessee, Knoxville, Tennessee (K.A.L.-R.); the Department of Educational and Counseling Psychology, University of Kentucky, Lexington, Kentucky (K.A.M.); the Department of Psychology, Arizona State University, Tempe, Arizona (A.L.K.); and the Department of Family Medicine, University of Tennessee Graduate School of Medicine, Knoxville, Tennessee (A.J.K.).

View larger version (12K): [in a new window]   Figure 1. Repressive coping as measured by the Index of Self-Regulation of Emotion for hypertensives and normotensives in the drug versus placebo conditions.

View larger version (14K): [in a new window]   Figure 2. Systolic blood pressure over baseline, interview, and recovery for hypertensives and normotensives in drug and placebo conditions.

View larger version (7K): [in a new window]   Figure 3. Scatterplot of disclosure (life concerns) and systolic blood pressure in hypertensives with naltrexone.